Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers

Memorial Sloan Kettering Cancer Center · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
lungcancerplatinum
lung cancer, osimertinib, platinum, etoposide, egfr mutant, 18-211, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 832211
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.